Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
894 results
894
Total Filings
$6934.4B
Total Raised
69
424B4 Offerings
254
ATM Programs
126
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | TPET | Energy | Oil & Gas Exploration & Production | $3M | ATM | — | $0.31 | — | — | — | — | Trio Petroleum Corp is selling up to $1,641,000 of common stock through an ATM agreement with Ladenburg Thalmann at market prices; proceeds will be used for general corporate purposes. |
| Mar 10 | BLNE | Consumer Defensive | Beverages - Wineries & Distilleries | $15M | ATM | — | $1.06 | — | 368K | — | — | Beeline Holdings (BLNE) is conducting an at-the-market offering of up to $15,000,000 in common stock through Ladenburg Thalmann, with proceeds for general corporate purposes. |
| Mar 10 | RCKTW | — | — | — | ATM |
$5.11
floor
|
— | — | — | — | Cantor Fitzgerald, Cowen | Rocket Lab USA Inc. selling up to $100 million common stock at-the-market through Cantor Fitzgerald; proceeds for general corporate purposes. |
| Mar 10 | VENU | Consumer Cyclical | Restaurants | $96M | Public Offering |
$5.00
floor
|
$2.65 | -47.0% | 14.3M | $72M | — | Venu Holding Corporation is raising approximately $57.4 million by selling 14.34 million common shares at $4.00 each plus 18.75 million common warrants; proceeds will fund operations and general corporate purposes. |
| Mar 10 | XWIN | Consumer Cyclical | Furnishings, Fixtures & Appliances | $179M | Public Offering |
$4.23
floor
|
$8.63 | +104.0% | 8.5M | $36M | — | XMAX Inc. is selling 8,500,000 common shares at $4.23 per share to raise approximately $35,955,000 to selected investors pursuant to a securities purchase agreement. |
| Mar 9 | ALOY | Basic Materials | Other Precious Metals | $41M | Public Offering | — | $10.77 | — | 2.7M | — | Needham | Real Aloy Inc. is selling 2,702,702 common shares at $18.50 per share, raising approximately $50 million, with net proceeds of $47.3 million before expenses; use of proceeds not specified in excerpt. |
| Mar 9 | DNTH | Healthcare | Biotechnology | $3.8B | Public Offering | — | $101.28 | — | — | — | Jefferies, Cowen, Evercore, Stifel | Denthon Group Inc. (DNTH) is raising $400 million through a public offering of common stock and pre-funded warrants on Nasdaq, with proceeds for general corporate purposes. |
| Mar 9 | VEEE | Consumer Cyclical | Auto - Recreational Vehicles | $49M | Public Offering |
$1.97
floor
|
$24.86 | +1161.9% | — | — | — | Twin Vee PowerCats Co. is offering common stock on a best efforts basis at an unspecified price per share; specific share count, offering price, and use of proceeds are not disclosed in this preliminary prospectus supplement. |
| Mar 9 | CLDWW | — | — | — | Public Offering |
$0.50
floor
|
— | — | 9.8M | $5M | — | Calidi Biotherapeutics selling up to 703,731 common stock units at $0.50 each with warrants; raising ~$352 million for working capital and general corporate purposes. |
| Mar 9 | XENE | Healthcare | Biotechnology | $5.4B | Public Offering |
$41.94
floor
|
$67.72 | +61.5% | — | — | Jefferies, Cowen, Stifel | Xenon Pharmaceuticals Inc. is offering $500 million of common shares at an undisclosed price per share, with proceeds to fund operations and general corporate purposes. |
| Mar 9 | SPRB | Healthcare | Biotechnology | $36M | ATM |
$55.87
floor
|
$46.36 | -17.0% | — | — | Jefferies | Spright Ltd (SPRB) is selling up to $75 million in common stock at-the-market through Jefferies at $55.87/share, with proceeds for general corporate purposes. |
| Mar 9 | ENGNW | — | — | — | ATM |
$8.71
floor
|
— | — | — | — | — | Engene Inc. may raise up to $100 million through an at-the-market offering of common shares via Leerink Partners, with proceeds for general corporate purposes. |
| Mar 9 | USEG | Energy | Oil & Gas Exploration & Production | $40M | Public Offering | — | $1.19 | — | 8.8M | — | — | U.S. Energy Corp. is offering 8,800,000 common shares at $1.00 per share, raising $8.8 million gross proceeds for general corporate purposes. |
| Mar 6 | TRNR | Consumer Cyclical | Personal Products & Services | $4M | ATM |
$11.40
floor
|
$2.94 | -74.2% | — | — | — | Interactive Strength Inc. is raising up to $6,057,000 through an at-the-market offering of common stock via H.C. Wainwright at $1.73/share; proceeds will replenish the shelf registration for future capital needs. |
| Mar 6 | ALOY | Basic Materials | Other Precious Metals | $41M | ATM | — | $10.77 | — | 260K | — | — | Real Alloyz Inc. (ALOY) suspended its at-the-market offering after selling 260,000 common shares for $2.21 million gross proceeds through Alexander Capital L.P. since July 2025. |
| Mar 6 | IBIO | Healthcare | Biotechnology | $15M | ATM | — | $1.44 | — | — | — | Jefferies | iBio may sell up to $100 million in common stock at market prices through Jefferies as sales agent, with proceeds for general corporate purposes. |
| Mar 6 | VENU | Consumer Cyclical | Restaurants | $96M | Public Offering |
$4.84
floor
|
$2.65 | -45.2% | — | — | — | Venu Holding Corporation is selling common stock and warrants at an undisclosed price per unit; specific share counts and proceeds use are blank in this preliminary prospectus supplement. |
| Mar 6 | BXP | Real Estate | REIT - Office | $10.8B | ATM | — | $67.72 | — | — | — | BofA, J.P. Morgan, Jefferies, Morgan Stanley, Truist, Wells Fargo | BXP, Inc. established a $1 billion at-the-market common stock offering program through thirteen sales agents, with proceeds for general corporate purposes and potential debt reduction. |
| Mar 6 | VCIG | Industrials | Consulting Services | $304,962 | Public Offering |
$5.62
floor
|
$2.12 | -62.3% | — | — | — | VCIG Global is raising $15 million from a single institutional investor through three tranches of $5 million each, selling ordinary shares, pre-funded warrants, and common warrants at $4.09 per share; proceeds will fund operations. |
| Mar 6 | CLDWW | — | — | — | Public Offering | — | — | — | — | — | — | # Calidi Biotherapeutics (CLDWW) Offering Summary **Calidi Biotherapeutics is conducting a firm commitment underwritten public offering of common stock units with Series J, K, and L warrants; specific price and proceeds allocation not disclosed in this preliminary prospectus supplement dated March 5, 2026.** |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →